Answers are grounded in this paper and cite their sources.
We read with interest the report (1) on IgG antibodies against tissue transglutaminase (tTG) in patients positive for anti-double-stranded DNA with systemic lupus erythematosus and in patients positive for anti-SSA/SSB. We agree with the authors’ hypothesis that in some autoimmune disorders, such as systemic lupus erythematosus, the content of apoptotic bodies (including tTG) could come into contact with the immune system, leading to an autoimmune response. Nevertheless, some aspects of this study require comments. tTG, an intracellular enzyme, has recently been proposed as the major autoantigen of anti-endomysial antibodies (EMAs), and measurements of IgA anti-tTG antibodies are used in the diagnostic evaluation of celiac disease (CD) (2)(3)(4). Furthermore, the presence of IgG anti-tTG antibodies has been associated with IgG1 EMA positivity in CD patients either with or without selective IgA deficiency (5)(6). To exclude CD, we believe that determination of serum IgG1 EMA could be useful in the above-mentioned antinuclear-positive patients (1).
No takes yet. Share an insight, caveat, or question.
Tola et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: